UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65:87-108; PMID:25651787; http://dx.doi.org/10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009; 374:477-90; PMID:19625077; http://dx.doi.org/10.1016/S0140-6736(09)60617-6
   PubMed Web of Science ®Google Scholar
• Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, Shinga J, Mizutani-Koseki Y, Toyoda T, Okamura K, et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007; 450:908-12; PMID:17994007; http://dx.doi.org/10.1038/nature06397
   PubMed Web of Science ®Google Scholar
• Bostick M, Kim JK, Esteve PO, Clark A, Pradhan S, Jacobsen SE. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007; 317:1760-4; PMID:17673620; http://dx.doi.org/10.1126/science.1147939
   PubMed Web of Science ®Google Scholar
• Macaluso M, Montanari M, Noto PB, Gregorio V, Bronner C, Giordano A. Epigenetic modulation of estrogen receptor-α by pRb family proteins: a novel mechanism in breast cancer. Cancer Res 2007; 67:7731-7; PMID:17699777; http://dx.doi.org/10.1158/0008-5472.CAN-07-1476
   PubMed Web of Science ®Google Scholar
• Daskalos A, Oleksiewicz U, Filia A, Nikolaidis G, Xinarianos G, Gosney JR, Malliri A, Field JK, Liloglou T. UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. Cancer 2011; 117:1027-37; PMID:21351083; http://dx.doi.org/10.1002/cncr.25531
   PubMed Web of Science ®Google Scholar
• Unoki M, Daigo Y, Koinuma J, Tsuchiya E, Hamamoto R, Nakamura Y. UHRF1 is a novel diagnostic marker of lung cancer. Br J Cancer 2010; 103:217-22; PMID:20517312; http://dx.doi.org/10.1038/sj.bjc.6605717
   PubMed Web of Science ®Google Scholar
• Sabatino L, Fucci A, Pancione M, Carafa V, Nebbioso A, Pistore C, Babbio F, Votino C, Laudanna C, Ceccarelli M, et al. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression. Oncogene 2012; 31:5061-72; PMID:22286757; http://dx.doi.org/10.1038/onc.2012.3
   PubMed Web of Science ®Google Scholar
• Wang F, Yang YZ, Shi CZ, Zhang P, Moyer MP, Zhang HZ, Zou Y, Qin HL. UHRF1 promotes cell growth and metastasis through repression of p16(ink(4)a) in colorectal cancer. Ann Surg Oncol 2012; 19:2753-62; PMID:22219067; http://dx.doi.org/10.1245/s10434-011-2194-1
   PubMed Web of Science ®Google Scholar
• Babbio F, Pistore C, Curti L, Castiglioni I, Kunderfranco P, Brino L, Oudet P, Seiler R, Thalman GN, Roggero E, et al. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Oncogene 2012; 31:4878-87; PMID:22330138; http://dx.doi.org/10.1038/onc.2011.641
   PubMed Web of Science ®Google Scholar
• Unoki M, Kelly JD, Neal DE, Castiglioni I, Kunderfranco P, Brino L, Oudet P, Seiler R, Thalman GN, Roggero E. UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer 2009; 101:98-105; PMID:19491893; http://dx.doi.org/10.1038/sj.bjc.6605123
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang Z, Zhu Z, Castiglioni I, Kunderfranco P, Brino L, Oudet P, Seiler R, Thalman GN, Roggero E. Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1. PLoS One 2014; 9:e104252; PMID:25272010; http://dx.doi.org/10.1371/journal.pone.0104252
   PubMed Web of Science ®Google Scholar
• Mudbhary R, Hoshida Y, Chernyavskaya Y, Jacob V, Villanueva A, Fiel MI, Chen X, Kojima K, Thung S, Bronson RT, et al. UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell 2014; 25:196-209; PMID:24486181; http://dx.doi.org/10.1016/j.ccr.2014.01.003
   PubMed Web of Science ®Google Scholar
• Bronner C, Krifa M, Mousli M. Increasing role of UHRF1 in the reading and inheritance of the epigenetic code as well as in tumorogenesis. Biochem Pharmacol 2013; 86:1643-9; PMID:24134914; http://dx.doi.org/10.1016/j.bcp.2013.10.002
   PubMed Web of Science ®Google Scholar
• Bronner C, Achour M, Arima Y, Chataigneau T, Saya H, Schini-Kerth VB. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther 2007; 115:419-34; PMID:17658611; http://dx.doi.org/10.1016/j.pharmthera.2007.06.003
   PubMed Web of Science ®Google Scholar
• Mousli M, Hopfner R, Abbady AQ, Monté D, Jeanblanc M, Oudet P, Louis B, Bronner C. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br J Cancer 2003; 89:120-7; PMID:12838312; http://dx.doi.org/10.1038/sj.bjc.6601068
   PubMed Web of Science ®Google Scholar
• Zhou L, Zhao X, Han Y, Monté D, Jeanblanc M, Oudet P, Louis B, Bronner C. Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis. FASEB J 2013; 27:4929-39; PMID:23982143; http://dx.doi.org/10.1096/fj.13-233387
   PubMed Web of Science ®Google Scholar
• Mutoh H, Sakurai S, Satoh K, Tamada K, Kita H, Osawa H, Tomiyama T, Sato Y, Yamamoto H, Isoda N, et al. Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res 2004; 64:7740-7; PMID:15520178; http://dx.doi.org/10.1158/0008-5472.CAN-04-1617
   PubMed Web of Science ®Google Scholar
• Kim JK, Noh JH, Eun JW, Jung KH, Bae HJ, Shen Q, Kim MG, Chang YG, Kim SJ, Park WS, et al. Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer. Mol Cancer Res 2013; 11:62-73; PMID:23175521; http://dx.doi.org/10.1158/1541-7786.MCR-12-0332
   PubMed Web of Science ®Google Scholar
• Lin FC, Liu YP, Lai CH, Shan YS, Cheng HC, Hsu PI, Lee CH, Lee YC, Wang HY, Wang CH, et al. RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells. Oncogene 2012; 31:4302-16; PMID:22231444; http://dx.doi.org/10.1038/onc.2011.596
   PubMed Web of Science ®Google Scholar
• Su L, Liu X, Chai N, Lv L, Wang R, Li X, Nie Y, Shi Y, Fan D. The transcription factor FOXO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer. BMC Cancer 2014; 14:378; PMID:24886657; http://dx.doi.org/10.1186/1471-2407-14-378
   PubMed Web of Science ®Google Scholar
• Lee JM, Kim SS, Cho YS. The Role of PPARgamma in Helicobacter pylori Infection and Gastric Carcinogenesis. PPAR Res 2012; 2012:687570; PMID:22936949; http://dx.doi.org/10.1155/2012/687570
   PubMed Web of Science ®Google Scholar
• Hu H, Zhang Y, Zou M, Yang S, Liang XQ. Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer. J Cancer Res Clin Oncol 2010; 136:1407-14; PMID:20127252; http://dx.doi.org/10.1007/s00432-010-0795-x
   PubMed Web of Science ®Google Scholar
• Kim HJ, Song DE, Lim SY, Lee SH, Kang JL, Lee SJ, Benveniste EN, Choi YH. Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes. PLoS One 2011; 6:e26264; PMID:22022583; http://dx.doi.org/10.1371/journal.pone.0026264
   PubMed Web of Science ®Google Scholar
• Wong KY, Huang X, Chim CS. DNA methylation of microRNA genes in multiple myeloma. Carcinogenesis 2012; 33:1629-38; PMID:22715154; http://dx.doi.org/10.1093/carcin/bgs212
   PubMed Web of Science ®Google Scholar
• Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2012; 31:1609-22; PMID:21860412; http://dx.doi.org/10.1038/onc.2011.354
   PubMed Web of Science ®Google Scholar
• Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012; 143:550-63; PMID:22796521; http://dx.doi.org/10.1053/j.gastro.2012.07.009
   PubMed Web of Science ®Google Scholar
• Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Lattimore S, Akada M, Sunamura M, Prime W, Campbell F, Brentnall TA, et al. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 2005; 129:1454-63; PMID:16285947; http://dx.doi.org/10.1053/j.gastro.2005.08.012
   PubMed Web of Science ®Google Scholar
• Yang GL, Zhang LH, Bo JJ, Chen HG, Cao M, Liu DM, Huang YR. UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer. Med Oncol 2012; 29:842-7; PMID:21611839; http://dx.doi.org/10.1007/s12032-011-9983-z
   PubMed Web of Science ®Google Scholar
• Mulder KW, Wang X, Escriu C, Ito Y, Schwarz RF, Gillis J, Sirokmány G, Donati G, Uribe-Lewis S, Pavlidis P, et al. Diverse epigenetic strategies interact to control epidermal differentiation. Nat Cell Biol 2012; 14:753-63; PMID:22729083; http://dx.doi.org/10.1038/ncb2520
   PubMed Web of Science ®Google Scholar
• Hopfner R, Mousli M, Jeltsch JM, Voulgaris A, Lutz Y, Marin C, Bellocq JP, Oudet P, Bronner C. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res 2000; 60:121-8; PMID:10646863
   PubMed Web of Science ®Google Scholar
• Ying L, Lin J, Qiu F, et al. Epigenetic repression of RGS2 by UHRF1 promotes bladder cancer progression. FEBS J 2015; 282174-82; PMID:25323766
   Google Scholar
• Wu SM, Cheng WL, Liao CJ, et al. Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth. Int J Cancer 2015; 137:37-49; PMID:25430639
   Web of Science ®Google Scholar
• Alhosin M, Sharif T, Mousli M, Etienne-Selloum N, Fuhrmann G, Schini-Kerth VB, Bronner C. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J Exp Clin Cancer Res 2011; 30:41; PMID:21496237; http://dx.doi.org/10.1186/1756-9966-30-41
   PubMed Web of Science ®Google Scholar
• Jeanblanc M, Mousli M, Hopfner R, Bathami K, Martinet N, Abbady AQ, Siffert JC, Mathieu E, Muller CD, Bronner C. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle. Oncogene 2005; 24:7337-45; PMID:16007129; http://dx.doi.org/10.1038/sj.onc.1208878
   PubMed Web of Science ®Google Scholar
• Achour M, Jacq X, Ronde P, Alhosin M, Charlot C, Chataigneau T, Jeanblanc M, Macaluso M, Giordano A, Hughes AD, et al. The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. Oncogene 2008; 27:2187-97; PMID:17934516; http://dx.doi.org/10.1038/sj.onc.1210855
   PubMed Web of Science ®Google Scholar
• Shamma A, Suzuki M, Hayashi N, Kobayashi M, Sasaki N, Nishiuchi T, Doki Y, Okamoto T, Kohno S, Muranaka H, et al. ATM mediates pRB function to control DNMT1 protein stability and DNA methylation. Mol Cell Biol 2013; 33:3113-24; PMID:23754744; http://dx.doi.org/10.1128/MCB.01597-12
   PubMed Web of Science ®Google Scholar
• Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71; PMID:7545954; http://dx.doi.org/10.1126/science.7545954
   PubMed Web of Science ®Google Scholar
• Jin W, Chen L, Chen Y, Xu SG, Di GH, Yin WJ, Wu J, Shao ZM. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res Treat 2010; 123:359-73; PMID:19943104; http://dx.doi.org/10.1007/s10549-009-0652-2
   PubMed Web of Science ®Google Scholar
• Salomoni P, Ferguson BJ, Wyllie AH, Rich T. New insights into the role of PML in tumour suppression. Cell Res 2008; 18:622-40; PMID:18504460; http://dx.doi.org/10.1038/cr.2008.58
   PubMed Web of Science ®Google Scholar
• Guan D, Factor D, Liu Y, Wang Z, Kao HY. The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein. Oncogene 2013; 32:3819-28; PMID:22945642; http://dx.doi.org/10.1038/onc.2012.406
   PubMed Web of Science ®Google Scholar
• Shiotani A, Kamada T, Yamanaka Y, Manabe N, Kusunoki H, Hata J, Haruma K. Sonic hedgehog and CDX2 expression in the stomach. J Gastroenterol Hepatol 2008; 23 (Suppl 2):S161-6; PMID:19120891; http://dx.doi.org/10.1111/j.1440-1746.2008.05406.x
   PubMed Web of Science ®Google Scholar
• van der Vos KE, Coffer PJ. The extending network of FOXO transcriptional target genes. Antioxid Redox Signal 2011; 14:579-92; PMID:20673124; http://dx.doi.org/10.1089/ars.2010.3419
   PubMed Web of Science ®Google Scholar
• Lam EW, Brosens JJ, Gomes AR, Koo CY. Forkhead box proteins: tuning forks for transcriptional harmony. Nat Rev Cancer 2013; 13:482-95; PMID:23792361; http://dx.doi.org/10.1038/nrc3539
   PubMed Web of Science ®Google Scholar
• Zhou L, Shang Y, Liu C, Li J, Hu H, Liang C, Han Y, Zhang W, Liang J, Wu K. Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer. Int J Cancer 2014; 135:2329-37; PMID:24706505; http://dx.doi.org/10.1002/ijc.28883
   PubMed Web of Science ®Google Scholar